# FDA approved Zolgensma gene therapy for pediatric spinal muscular atrophy

Date: 2019

_No public text on this fact yet._

## Drivers

- Biotechnology Innovation: https://factrail.ai/drivers/biotechnology-innovation

## Sources

_Sources are listed on the canonical page._

## Methodology

https://factrail.ai/methodology

Canonical: https://factrail.ai/facts/fda-zolgensma-sma-gene-therapy-approval-2019